Pharmaceutical Industry

We Can Teach Old Drugs New Tricks -- and We Should

Michael Manganiello | Posted 05.08.2012

Read More: HIV/AIDS, National Center for Advancing Translational Sciences, Pharmaceutical Industry, Kathleen Sebelius, National Institutes of Health, Azt, Politics News
Michael Manganiello

There isn't one person in this country who hasn't been touched by ALS, Parkinson's, MS, Alzheimer's, spinal cord injury, cancer, diabetes and thousands of other diseases and conditions. And for every American who is suffering, there is potentially an already approved drug waiting to be rediscovered.

Read Post

Spring Cleaning the Medicine Cabinets, and Other Ways to Combat Rx Abuse

John J. Castellani | Posted 05.07.2012

Read More: Prescription Drugs, Pharmaceutical Industry, Takeback Programs, Drug Enforcement Administration, Prescription Drug Abuse, Smartrx, Health News, Healthy Living News
John J. Castellani

Now, more than ever, it's crucial for all of us to inventory whether we have unused and expired medicine in our homes and take immediate, safe steps to dispose of them -- before they end up in the wrong hands.

Read Post

Bernie Sanders Advocates a Free Market in AIDS Drugs

Dean Baker | Posted 05.07.2012

Read More: Aids, HIV/AIDS, Prescription Drugs, Pharmaceutical Industry, Budget, Drug Patents, Prize System, Business News
Dean Baker

There are more efficient mechanisms than patent monopolies to finance drug research. Vermont Senator Bernie Sanders is proposing one such mechanism, a prize system, be adopted to support research on AIDS drugs.

Read Post

Charges Made In Historic $80 Million Drug Heist

AP | CURT ANDERSON | Posted 05.03.2012

Read More: Largest Drug Heists, Drug Heist, Eli Lilly Drug Heist, Video, Pharmaceutical Industry, Pharmaceutical Theft, Biggest Drug Heists, Eli Lilly, Crime News

MIAMI -- Federal prosecutors say 11 people are charged in Florida with running a major pharmaceutical theft ring that targeted warehouses and tractor-...

Read Whole Story

Big Pharma Company Battles To Buy Gene Science Firm

Reuters | Ben Hirschler | Posted 04.25.2012

Read More: Glaxosmithkline, Big Pharma, Dna, Pharmaceutical Industry, Biotechnology, Video, Genes, Genome, Reuters, Human Genome Sciences, Pharmaceuticals, Craig Venter, Human Genome, Gsk, Science News

By Ben Hirschler LONDON (Reuters) - Drugmaker GlaxoSmithKline said on Wednesday its $2.6 billion bid for long-time partner Human Genome...

Read Whole Story

Giant Company Allegedly Hid Risks Of Drug That Made Billions

AP | CHUCK BARTELS | Posted 04.12.2012

Read More: Johnson and Johnson, Big Pharma, Pharmaceutical Industry, Video, Johnson & Johnson, Risperdal Risks, Risperdal, Business News, Johnson and Johnson Risperdal Risks, Business News

LITTLE ROCK, Ark. -- A Johnson & Johnson subsidiary downplayed and hid risks associated with the antipsychotic drug Risperdal, a jury determined Tuesd...

Read Whole Story

An Essential Balance: Preserving Our Commitment to Patient Safety

John J. Castellani | Posted 04.29.2012

Read More: Pharmaceutical Industry, Congress, Pdufa, Fda, Medicine, Health Care, New Research, Politics News
John J. Castellani

If one thing is true about biopharmaceutical research, it's that the quest to bring safe and effective new medicines to patients is anything but a one-size-fits-all model.

Read Post

Paul Blumenthal

Auction 2012: How The Drug Industry Games Washington

HuffingtonPost.com | Paul Blumenthal | Posted 02.01.2012

Read More: Health Care Bill, Pay for Delay, Health Care for America Now, Auction 2012, Charles Grassley, Drug Industry, Lobbying, Medicare Part D, Olympia Snowe, Debbie Stabenow, Canada Drugs, Barack Obama, Campaign Finance, Video, Pharmaceutical Industry, Prescription Drugs, Max Baucus, Affordable Care Act, Medicare, Byron Dorgan, Health Care, Politics News

Auction 2012 is a weeklong series in collaboration with "The Dylan Ratigan Show" and United Republic. When he first ran for president, Barack Obama...

Read Whole Story

Big Pharma Is Innovating With Social Media -- Really

Rosina Samadani | Posted 04.01.2012

Read More: Ginger.io, West Wireless Health, Open Data, Apps, Crowdsourcing, Pfizer, Innovation, Sanofi-Aventis, Patients, iPhone Apps, Center for Medicare and Medicaid Services, Pharmaceutical Companies, Social Media, Pharmaceutical Industry, Diabetes, True Ventures, Technology, Health Care, Business News
Rosina Samadani

When big pharma leverages technology, open data and social media to develop innovative patient-facing apps, it's a win to the fourth power.

Read Post

Drug Giant's Profit Plunges After Introduction of Generic Lipitor

AP | LINDA A. JOHNSON | Posted 04.01.2012

Read More: Big Pharma, Quarterly Earnings, Pharmaceutical Industry, Video, Pfizer-Earnings-2011, Earnings Season, Lipitor, Pfizer Earnings 4q 2011, Business News, Pfizer Earnings, Generic Lipitor, Drug Makers, Business News

Pfizer Inc.'s fourth-quarter profit fell by half because it sold less Lipitor, the cholesterol fighter that's the biggest drug ever to go off patent, ...

Read Whole Story

Paula Deen at the Crossroads: Punch Line or Role Model?

Nancy Huehnergarth | Posted 03.20.2012

Read More: Big Food, Type 2 Diabetes, Healthy Eating Habits, Paula Deen Diabetes, Pharmaceutical Industry, Food Network Star Diabetes, Food Network, Paula Deen, Victoza, Pharmaceuticals, Novo Nordisk, Food News
Nancy Huehnergarth

Could Deen's diabetes diagnosis act as a wake up call to those in denial about the relationship between what you eat and your health?

Read Post

The Psychiatric Drugging of America's Foster Children

Dr. Peter Breggin | Posted 12.22.2011

Read More: Medical Ethics, Psychiatry, Pharmaceutical Companies, Pharmaceutical Industry, Mental Health, Antipsychotic Drugs, Drug Companies, Psychiatric Drugs, Foster Children, Antipsychotics, Healthy Living News
Dr. Peter Breggin

There were approximately 662,000 children in foster care in the U.S. in 2010. Now, there is a Government Accounting Office report confirming that foster children in five states are receiving shocking amounts of psychiatric drugs.

Read Post

British Drug Giant To Slash More Than 1,000 U.S. Jobs

Posted 12.07.2011

Read More: Big Pharma, Layoffs, Pharmaceutical Companies, Pharmaceutical Industry, Video, Job Cuts, Business News, Astrazeneca, Astrazeneca Job Cuts, Business News

LONDON (Reuters) - AstraZeneca is cutting nearly a quarter of its U.S. sales force in a second wave of redundancies in as many months as it seeks ...

Read Whole Story

Child's Play: The PBM Merger That Can Learn From Childhood Lessons

John Horton | Posted 02.01.2012

Read More: Pharmaceutical Industry, Pharmacies, Health Care, Mergers, Business News
John Horton

As regulators consider the Express Scripts/Medco merger, they should consider the patient's point of view -- and whether the market is already so concentrated that the proposed merger will simply make an existing problem worse.

Read Post

Drug Giant To Pay Hundreds Of Millions To Settle Charge

Posted 11.22.2011

Read More: Big Pharma, Merck & Co, Pharmaceutical Industry, Video, Merck-Vioxx-Settlement, Merck-Vioxx-Ads, Vioxx, Vioxx Settlement, Merck Vioxx Charge, Business News

Merck & Co will pay roughly $950 million to settle criminal and civil charges that it promoted the painkiller Vioxx for an unapproved use, the U.S...

Read Whole Story

Drugmaker To Pay Huge Sum To Settle Bribery Probe: Report

AP | By The Associated Press | Posted 11.21.2011

Read More: Big Pharma, Pharmaceutical Companies, Pharmaceutical Industry, Video, Pfizer Settlement, Pfizer, Business News, Pfizer Bribery, Bribery, Business News

-- Pfizer Inc. will pay at least $60 million to settle allegations by the U.S. government that the drugmaker paid bribes to win overseas business, ac...

Read Whole Story

Who Owns the Data?

Susan M. Love | Posted 01.08.2012

Read More: Breast Cancer Research, Pharmaceutical Industry, Stephen Friend, Drug Companies, Cancer Research, Breast Cancer, Dr. Susan Love, Fda, Impact News
Susan M. Love

Clinical trial data are typically collected by drug companies or academics specifically for their own trials on their own new potential medicines or pet theories. This means the data is often locked away in proprietary silos.

Read Post

Book Review: Anatomy of an Epidemic by Robert Whitaker

DJ Jaffe | Posted 11.03.2011

Read More: Mental Illness, Big Pharma, Psychiatry, Anatomy of an Epidemic, Mentally Ill, Pharmaceutical Industry, Schizophrenia, Robert Whitaker, Psychology, Books News
DJ Jaffe

What's amazing about Anatomy of an Epidemic: Magic bullets, psychiatric drugs, and the astonishing rise of mental illness in America (2010, Broadway P...

Read Post

Drug Giant Beats Profit, Sales Forecasts

Posted 01.01.2012

Read More: Big Pharma, Earnings, Pharmaceutical Industry, Quarterly Earnings, Video, Drug Companies, Pfizer Earnings 2011, Business News, Pfizer, Corporate Earnings, Business News

Pfizer Inc reported better-than-expected quarterly results, helped by sales growth of its prescription drugs in emerging markets and its animal he...

Read Whole Story

The Sales Rep Who Loved, and Why You Should Be Very Afraid

Lisa Earle McLeod | Posted 12.25.2011

Read More: Competition, Pharmaceutical Industry, Sales, Business Management, Business Sales Training, Business News
Lisa Earle McLeod

People need to be paid fairly for their work. But passionate employees outperform incentive-driven employees every day of the week.

Read Post

The Role Of Patents In Inflating Drug Costs: An Excerpt From 'Deadly Monopolies'

Posted 12.21.2011

Read More: Big Pharma, Pharmaceutical Companies, Video, Pharmaceutical Industry, Harriet A. Washington, Medical Patents, Prescription Drugs, Business News, Deadly-Monopolies, Drug Patents, Pharmaceuticals, Healthcare, Patents, Business News

This is an adaption from "Deadly Monopolies" Harriet A. Washington's new book, which explores how the corporate takeover of the medical industry is af...

Read Whole Story

We Should Stop Subsidizing the Price of Europe's Prescription Drugs

Hava Volterra | Posted 12.10.2011

Read More: Big Pharma, Pharmaceutical Industry, Health Care, Politics News
Hava Volterra

An article in the Wall Street Journal caught my eye last week. NICE, the British national health care service's drug regulator, has decided it will n...

Read Post

Shooting Itself In the Foot: The Broken Promises of the U.S. Trade Agenda

Tido von Schoen-Angerer | Posted 11.14.2011

Read More: International Trade, HIV/AIDS, U.S. Trade Representative, Free Trade Agreements, Doctors Without Borders, Pharmaceutical Industry, HIV Medications, Developing Countries, Msf, Access-to-Medicines, Tpp, Trans-Pacific Partnership, Access to Medicines, World News
Tido von Schoen-Angerer

In the Chicago trade talks, the U.S. is trying to club up with countries in a deal that keeps the cost of medicines high.

Read Post

In Defense Of WikiLeaks: Looking At Cables On Pharmaceutical Drugs And Trade Pressures

James Love | Posted 11.04.2011

Read More: Pharmaceutical Industry, Government Leaks, Pharmaceutical Drugs, Wikileaks, State Department, Politics News
James Love

What have the WikiLeaks cables given the public? For those who care about such things, we now have a much clearer and documented view of the actual policies carried out by the US government, and also by many other governments.

Read Post

FDA, It's Time to Rein in Misleading Pharmaceutical Ads

Jerrold S. Parker | Posted 10.01.2011

Read More: Pharmaceutical Industry, Advertising, Healthy Living Body, Pharma Ads, Health Care, Pharmaceutical Ads, Big Pharma, Yaz Advertisements, Misleading Pharmaceuticals, Healthy Living News
Jerrold S. Parker

Therefore, it is up to regulators to ensure that dangerous drugs are kept off the airwaves -- as well as off the shelves. The use of clever marketing to mask the potential risks of popular products is a universal issue.

Read Post